Müller, Thomas
St. Joseph-Krankenhaus
7 papers on CoChatORCID 0000-0002-6799-0753
Most cited papers
- Verified
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 3,836
- Verified
Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 801
- Verified
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
Müller, T. (2015) · Drugs
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 190
- Verified
Functional polymorphisms in dopaminergic genes modulate neurobehavioral and neurophysiological consequences of sleep deprivation
Holst, S. C., Müller, T., Valomon, A., Seebauer, B., Berger, W., & Landolt, H.-P. (2017) · Scientific Reports
Sleep and Work-Related FatigueSleep and Wakefulness Research
Cited by 45
- Verified
IMI – oral biopharmaceutics tools project – evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds
Margolskee, A., Darwich, A. S., Pepin, X., Pathak, S. M., Bolger, M. B., Aarons, L., Rostami-Hodjegan, A., Angstenberger, J., Graf, F., Laplanche, L., et al. (2017) · European Journal of Pharmaceutical Sciences
Drug Solubulity and Delivery SystemsPharmaceutical studies and practices
Cited by 43
- Verified
A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson’s disease patients.
Wahl, C., Kautzmann, S., Krebiehl, G., Strauss, K., Woitalla, D., Müller, T., Bauer, P., Riess, O., & Krüger, R. (2008) · Journal of Neural Transmission
Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways
Cited by 22
- Verified
Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation
Hermann, D. M., Bacigaluppi, M., Bassetti, C. L., Bassotti, G., Boltze, J., Chan, A., Dalkara, T., Denes, A., Diez-Tejedor, E., Dodel, R., et al. (2025) · Exploration of Neuroscience
Health and Medical Research ImpactsAnimal testing and alternatives
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free